Corcept Therapeutics is a pioneering biotechnology company dedicated to unlocking the potential of cortisol modulation. With over 25 years of expertise, they have developed more than 1,000 selective cortisol modulators and secured FDA approval for the first treatment for hypercortisolism (Cushing’s syndrome). The company continues to drive innovation across endocrinology, oncology, metabolism, and neurology through ongoing research and development.
Corcept is a biotechnology company focused on researching and developing cortisol modulators for treating serious diseases. They are seeking an Associate Medical Director/Medical Director, Oncology to participate in oncology clinical development, clinical guidance, scientific oversight, and clinical protocol design. This role will act as a key team member contributing to the advancement of the therapeutic potential of cortisol modulation.
Corcept Therapeutics is a pioneering biotechnology company dedicated to unlocking the potential of cortisol modulation. With over 25 years of expertise, they have developed more than 1,000 selective cortisol modulators and secured FDA approval for the first treatment for hypercortisolism (Cushing’s syndrome). The company continues to drive innovation across endocrinology, oncology, metabolism, and neurology through ongoing research and development.
Arrowhead Pharmaceuticals